ABSTRACT
Background Most diagnostic frameworks treat disease as static, overlooking its inherently dynamic and continuous progression. Noninvasive biomarkers capable of capturing physiological trajectories are critically needed for proactive health management.
Methods We developed a breath-based health navigation framework using exhaled volatile organic compounds (VOCs) as integrative, real-time indicators of systemic metabolism and immunity. Breath profiles were collected from healthy individuals and patients with nonalcoholic steatohepatitis (NASH, recently redefined as metabolic dysfunction–associated steatohepatitis, MASH), hepatocellular carcinoma (HCC), and periodontitis (PD). Multidimensional analysis and trajectory-informed mapping were applied to project individual health states into a low-dimensional physiological space.
Results Ratio-normalized VOC profiles revealed disease-specific metabolic signatures across P450-derived and microbiota-derived compounds. Machine learning achieved high diagnostic accuracy for distinguishing health, NASH, HCC, and PD, while dimensionality reduction and topological analysis visualized a continuous progression from health to advanced liver disease. This approach captured preclinical shifts and transitional states often missed by static diagnostics.
Conclusions Exhaled VOCs can serve as dynamic biomarkers for mapping health–disease transitions. By offering clinicians an intuitive map to locate patients within the health–disease continuum and anticipate their trajectories, this framework enables proactive decision-making and personalized intervention strategies. Collectively, our work points toward a paradigm shift in disease monitoring, with future integration into portable sensing technologies for noninvasive, continuous health-state assessment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partially supported by the Development Project for Extremely Early Diagnostics Technologies for Human Diseases of Aichi Prefecture in Japan (K.S.; W.S.; Y.S.; M.M.), the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 20H04283 (Y.S.), and the Japan Science and Technology Agency (JST) SPRING Grant Number JPMJSP2140 (K.T.S.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Committee for Clinical Research of Hiroshima University gave ethical approval for this work (approval number E-922).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This revised version includes the following changes from the previous version: Supplemental Figure 4 and Figure 5 were added. The Acknowledgments section and Author Contributions section were revised.
DATA AVAILABILITY
The datasets generated and/or analyzed during the current study are not publicly available in accordance with the ethical guidelines set by the Japanese government for medical and biological research involving human participants.
